Verastem | VSTM - Despesas Operacionais





Despesas Operacionais Alterar Data
AbbVie USD 10.27B 538M 2026-03
Alaunos Therapeutics USD 1.19M 148K 2025-09
AstraZeneca USD 8.18B 4.35B 2026-03
Curis USD 9.02M 23.01M 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
Incyte USD 5.62B 4.5B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Novartis USD 9.29B 507M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
TG Therapeutics USD 170.12M 28.04M 2026-03
Verastem USD 59.01M 21.98M 2025-12